Chromatin remodeller CHD7 is required for GABAergic neuron development by promoting PAQR3 expression
Mutations in the chromatin remodeller-coding gene CHD7 cause CHARGE syndrome (CS). CS features include moderate to severe neurological and behavioural problems, clinically characterized by intellectual disability, attention-deficit/hyperactivity disorder and autism spectrum disorder. To investigate...
Gespeichert in:
Veröffentlicht in: | EMBO reports 2021-06, Vol.22 (6), p.e50958-n/a |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Mutations in the chromatin remodeller-coding gene
CHD7
cause CHARGE syndrome (CS). CS features include moderate to severe neurological and behavioural problems, clinically characterized by intellectual disability, attention-deficit/hyperactivity disorder and autism spectrum disorder. To investigate the poorly characterized neurobiological role of
CHD7
, we here generate a zebrafish
chd7
−/−
model.
chd7
−/−
mutants have less GABAergic neurons and exhibit a hyperactivity behavioural phenotype. The GABAergic neuron defect is at least in part due to downregulation of the CHD7 direct target gene
paqr3b
, and subsequent upregulation of MAPK/ERK signalling, which is also dysregulated in
CHD7
mutant human cells. Through a phenotype-based screen in
chd7
−/−
zebrafish and
Caenorhabditis elegans
, we show that the small molecule ephedrine restores normal levels of MAPK/ERK signalling and improves both GABAergic defects and behavioural anomalies. We conclude that
chd7
promotes
paqr3b
expression and that this is required for normal GABAergic network development. This work provides insight into the neuropathogenesis associated with CHD7 deficiency and identifies a promising compound for further preclinical studies.
SYNOPSIS
Loss-of-function of
chd7
causes defects in GABAergic neuron development and behavioural anomalies reminiscent of CHARGE syndrome, which are rescued by genetic and pharmacological interventions in zebrafish.
Zebrafish
chd7
−/−
larvae display aberrant GABAergic network development and hyperactivity behavioral phenotypes.
Downregulation of
paqr3b
expression contributes to the GABAergic neuron defects in zebrafish
chd7
−/−
larval brains.
Ephedrine rescues the GABAergic neuron and behavioral defects.
Graphical Abstract
Loss-of-function of
chd7
causes defects in GABAergic neuron development and behavioural anomalies reminiscent of CHARGE syndrome, which are rescued by genetic and pharmacological interventions in zebrafish. |
---|---|
ISSN: | 1469-221X 1469-3178 |
DOI: | 10.15252/embr.202050958 |